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Abstract
Background: Using fixed receptor sites derived from high-
resolution crystal structures in structure-based drug design does
not properly account for ligand-induced enzyme conformational
change and imparts a bias into the discovery and design of novel
ligands. We sought to facilitate the design of improved drug leads
by defining residues most likely to change conformation, and then
defining a minimal manifold of possible conformations of a target
site for drug design based on a small number of identified flexible
residues.
Results : The crystal structure of thymidylate synthase from an
important pathogenic target Pneumocystis carinii (PcTS) bound to
its substrate and the inhibitor, BW1843U89, is reported here and
reveals a new conformation with respect to the structure of PcTS
bound to substrate and the more conventional antifolate inhibitor,
CB3717. We developed an algorithm for determining which
residues provide ‘soft spots’ in the protein, regions where
conformational adaptation suggests possible modifications for a
drug lead that may yield higher affinity. Remodeling the active site
of thymidylate synthase with new conformations for only three
residues that were identified with this algorithm yields scores for
ligands that are compatible with experimental kinetic data.
Conclusions: Based on the examination of many protein/ligand
complexes, we develop an algorithm (SOFTSPOTS) for identify-
ing regions of a protein target that are more likely to
accommodate plastically to regions of a drug molecule. Using
these indicators we develop a second algorithm (PLASTIC) that
provides a minimal manifold of possible conformations of a
protein target for drug design, reducing the bias in structure-based
drug design imparted by structures of enzymes co-crystallized with
inhibitors. ß 2001 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Computational approaches to structure-based drug de-
sign primarily rely on a high-resolution structure of the
target receptor against which small molecules can be
docked and scored for interactions. It is known, however,
that proteins undergo conformational changes to accom-
modate a ligand and increase the number of protein^li-
gand interactions. Once observed and described, these pro-
tein conformational changes are incorporated into a few
novel docking and scoring algorithms, as reported in a
recent review [1], but traditionally are not included due
to the lack of a comprehensive rule set that would allow
a fast and accurate algorithm. The existing algorithms that
allow a degree of protein £exibility include methods based
on multiple structure alignment or single semi-£exible
structures. Ensembles of structures for multiple-conforma-
tion docking are generated either through molecular dy-
namics [2,3], nuclear magnetic resonance solution struc-
tures, or by the existence of multiple crystal structures
[4]. Algorithms using semi-£exible single structures are
soft-docking techniques [5,6], minimization of side-chain
rotamers [7,8], and side-chain minimization using Monte-
Carlo simulations or molecular dynamics [9]. The majority
of these algorithms incorporate £exibility for all residues
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in the active site. We show here that if conformational
changes can be relegated to a few speci¢c residues and
their trajectories can be projected then it is possible to
compute a minimal manifold of structures as input to a
more exactly de¢ned docking target resulting in better
scores for known inhibitors.
Thymidylate synthase (TS) catalyzes the ¢nal step in the
de novo synthesis of deoxythymidine monophosphate
(dTMP) using the substrate deoxyuridine monophosphate
(dUMP), and a natural cofactor, 5,10-methylene tetrahy-
drofolate. Because of its essential role in DNA replication,
human TS is an anticancer drug target [10^14] and TS
from Pneumocystis carinii (PcTS) is an infectious disease
drug target [15]. Previous inhibitors developed against hu-
man TS have focused on substrate mimics : 5-£uorouridine
(5FU) [16] and cofactor mimics: CB3717 [11,17], ZD1694
[10] and BW1843U89 [14,18]. Several potent and novel
structure-based inhibitors such as AG337 [13], phenol-
phthalein [19] and antibacterial-speci¢c agents have also
been developed [20].
Additional disease targets of interest include TS from
other pathogens including Cryptococcus neoformans, Tox-
oplasma gondii and Cryptosporidium parvum. Since TS is
one of the most highly conserved enzymes it directly chal-
lenges and hones our ability to design, and/or to develop
ligands that show adequate species selectivity over human
TS.
The quest for an accurate evaluation of novel species-
speci¢c inhibitors discovered through computational
chemistry requires precise models of physically accessible
conformers of the several species. Identi¢cation and con-
formational sampling of only the principal residues in-
volved in ligand-induced structural changes will reduce
this otherwise potentially large conformational space for
each species. This reduction in enzyme conformational
sampling will allow the practical search for more speci¢c
inhibitors without the bias that is imparted by the confor-
mation of the enzyme in the ternary complex of a single
inhibited crystal structure.
In order to reduce the discrepancy between docking
scores of known good inhibitors to di¡erent conforma-
tions of the same active site, we sought to identify a min-
imal set of residues undergoing conformational changes,
and to compute a manifold of structures based on di¡er-
ent conformations for only those residues. The identi¢ca-
tion of £exible residues was ¢rst accomplished by compar-
ing crystal structures of PcTS bound to dUMP and either
CB3717 or BW1843U89 (a structure determination re-
ported here). This knowledge was then used ¢rst to see
if good scores could be correctly achieved by docking
against the limited manifold of structures generated by
incorporating discretely supplied rotamers of just this
small subset. It was then used again in the ¢rst iteration
of discovery aimed at de¢ning an algorithm (SOFT-
SPOTS) that would allow conformationally £exible resi-
dues to be identi¢ed in this or in any protein target, where
multiple structures either may or may not be available.
Using this predictive algorithm we identify three residues
in PcTS crucial to ligand adaptation. Allowing these three
residues to change conformation dramatically reduced the
rigid receptor problem for PcTS in computational docking
and scoring. The principles developed here can be applied
toward other enzymes that undergo conformational
change, allowing identi¢cation of speci¢c adaptable resi-
dues in those systems and a concomitant reduction in en-
zyme conformational sampling during docking.
2. Results and discussion
2.1. The crystal structure of PcTS Bound to dUMP and
BW1843U89
The crystal structure of PcTS bound to dUMP and
BW1843U89 was recently determined (statistics for the
data collection and model re¢nement are found in Table
1). The enzyme (Fig. 1) forms an obligate dimer that binds
two molecules of the substrate, dUMP, and two molecules
of the antifolate inhibitor, BW1843U89 (Fig. 2 compares
the two-dimensional structures of BW1843U89 with
CB3717, another antifolate inhibitor discussed in this
work). The crystal structure was solved with di¡raction
amplitudes extending to 1.9 Aî resolution, the highest res-
olution data for any eukaryotic TS structure solved to
date. The enzyme (MW 70 kDa) has a ¢ve-stranded L-
sheet interface and an active site comprised of nine con-
served helices. There are two dimers in the asymmetric
unit, related by a two-fold non-crystallographic symmetry
axis. The two monomers within a dimer are structurally
independent and have asymmetric interactions with the
Fig. 1. Ribbon diagram of the structure of PcTS bound to dUMP and
BW1843U89. The ligands are shown in black ball-and-stick representa-
tion.
CHBIOL 88 10-5-01 Cyaan Magenta Geel Zwart
446 Chemistry & Biology 8/5 (2001) 445^457
ligands. Both monomers show the ‘closed’ conformation:
the four C-terminal residues have moved approximately
4 Aî toward the active site to interact with the antifolate
and with residues in the active site. The ternary closed
conformation di¡ers from the apo or binary conformation
and serves to orient the ligands for catalysis, sequester
them from bulk solvent and protect the high-energy reac-
tion intermediates [21].
2.2. Ligand binding induces change in the receptor
One dimer of PcTS binds two molecules of the sub-
strate, dUMP, and antifolate, BW1843U89 (Ki = 16 nM
for PcTS), although each monomer has asymmetric inter-
actions with the ligands due to the mechanism of cooper-
ativity described below. Electron density for both ligands
was clearly visible in the initial maps (Fig. 3) and the
ligands were placed unambiguously in the model of the
enzyme. PcTS binds BW1843U89 by undergoing confor-
mational changes at the active site that maximize hydro-
phobic interactions (Fig. 4a,c) and where, speci¢cally, the
isoindolinone of BW1843U89 induces the majority of this
conformational change. There are at least ¢ve strong hy-
drophobic interactions between the inhibitor and the en-
zyme including those between Met 295, Trp 87 and Leu
205 with the benzoquinazoline. Ile 86 stacks against the
isoindolinone moiety that in turn stacks against Phe 209.
The isoindolinone moiety forms additional van der Waals
interactions with Gly 61. The Connolly surface represen-
tation in Fig. 4c reveals the tightly closed active site and in
comparison with the surface representation of PcTS/
dUMP/CB3717 (Fig. 4d) indicates the extent of the con-
formational change in the active site. There are also four
hydrogen bonds between the enzyme and the inhibitor:
Asp 202 with N2, the amide nitrogen of Gly 206 and
the keto oxygen O1A (both N2 and O1A are members
of the benzoquinazoline moiety), Glu 65 with N12, the
link between the benzoquinazoline and isoindolinone moi-
eties, and an ordered water molecule to the keto oxygen of
the isoindolinone.
Substrate interactions in the PcTS/dUMP/BW1843U89
complex (Fig. 4a) include hydrogen bonds between the
phosphate moiety and both arginine residues contributed
from the opposite monomer (Arg 153P and Arg 154P), Arg
199, Ser 200 and an ordered water molecule. The ribose of
dUMP forms hydrogen bonds to Tyr 242 and His 240 and
the pyrimidine base forms hydrogen bonds from O4 to an
ordered water molecule and from O4 and N3 to Asn 210.
Asn 202 forms a hydrogen bond to O2. This structure of
PcTS bound to dUMP and BW1843U89 reveals the can-
onical set of hydrogen bonds between TS and dUMP and
indicates the tightly closed nature of the BW1843U89 ac-
tive site (Fig. 4a,c). The structure of PcTS bound to
dUMP and CB3717 [15] (Fig. 4b) has many fewer hydro-
gen bonds between the enzyme and substrate, indicating a
more open active site complex. Hydrogen bonds present in
the BW1843U89-inhibited structure but not in the
CB3717-inhibited structure include: NH2 of Arg 199
and OP2, Ser 200 and OP1, NO of both Arg 154P and
153P to OP2 and OP3, respectively, His 240 and the ribose
O3P and from ordered water molecules to O4 and OP3.
Table 1
Re¢nement statistics for PcTS/dUMP/BW1843U89
Space group P21
Unit cell edges a = 54.4, b = 65.9, c = 184.9, L= 90.2
Resolution (Aî ) 50^1.9
Observed re£ections 530 911
Unique re£ections 104 488
Completeness (%) 90.3
I/c(I) 14.4
Rmerge 0.088
Rcryst (50^1.9 Aî ) 0.216
Rfree (50^1.9 Aî ) 0.247
Total no. atoms 10 125
No. water molecules 499
Rmsd bonds (Aî ) 0.0126
Rmsd angles (‡) 1.67
Average B-factor (Aî 2) 31.07
Fig. 2. Two-dimensional structures of the cofactor analogs.
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Thymidylate synthase converts the substrate, dUMP, to
a product, dTMP, in a reaction which involves a covalent
Michael addition of the active site cysteine (Cys 173 for
PcTS) to C6 of the pyrimidine ring of dUMP. In this
structure of PcTS bound to dUMP and BW1843U89, a
covalent bond forms in monomer A of each dimer in the
asymmetric unit, but not in monomer B. A similar situa-
tion occurs in the structure of PcTS bound to dUMP and
CB3717, for which we described a structure-based half-
the-sites reactivity mechanism [22]. The half-the-sites reac-
tive mechanism uses a relay of changes between subunits
and across the dimer interface to allow a covalent bond to
form for only one monomer of the dimeric enzyme. When
one covalent bond forms, a second is prevented from
forming simultaneously in the opposite monomer.
2.3. Failure of the rigid receptor hypothesis
Two computational experiments using DOCK 4.0, de-
veloped at UCSF, that dock and score ligands in active
site pockets reveal the inadequacies of the rigid receptor
model for TS. In one experiment, CB3717, in a rigid con-
formation, is docked into the PcTS site from the crystal
structure of PcTS/dUMP/CB3717 and also into the struc-
ture of PcTS from the dUMP/BW1843U89 complex. The
same swapping experiment is performed with the
BW1843U89 compound and the energy scores for all
four experiments are shown in Table 2 (analogous to a
vG calculation, a negative score indicates a stronger inter-
action). Force-¢eld scoring algorithms for these experi-
ments, for which the relative values are most relevant,
are based on both electrostatic and van der Waals inter-
actions [23]. The results show that both compounds score
well when docked into the site from which they were de-
rived and score poorly when docked into the ‘opposite’
PcTS structure. Simple minimization of the protein/inhib-
itor complexes at this step does not relieve this problem
since there is signi¢cant steric hindrance that is relieved
only by the choice of di¡erent rotamers for particular
residues. The radius of convergence of minimization is
small and cannot surmount the energy barriers between
rotameric states of residues. Similarly, including hydration
corrections for the e¡ect of solvent in the active site does
not relieve this problem since hydration corrections im-
prove the scores of docked ligands when the ligand can
actually ¢t into the active site and is not hindered by steric
Fig. 3. Electron density for the ligands and residues at the active site. The ligands are shown in black ball-and-stick representation.
Table 2
Force-¢eld scores from computational chemistry experiments
Structure from which site is derived Docked compound Top 500 compounds from ACD (low/high)
CB3717 BW1843U89
Rigid receptor/rigid ligands
PcTS/dUMP/CB3717 352.9a 344.7 345.3/360.8
PcTS/dUMP/BW1843U89 332.8 356.5 337.8/348.7
Rigid receptor/£exible ligands
PcTS/dUMP/CB3717 357.5 348.6 352.0/369.8
PcTS/dUMP/BW1843U89 351.7 356.6 348.3/359.2
Flexible receptor/rigid ligands
Remodeled PcTS/dUMP/CB3717 351.5
Remodeled PcTS/dUMP/BW1843U89 349.7
aScores in italics represent those from a compound docked into its native receptor.
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Fig. 4. LIGPLOT schematic of the interactions between PcTS and (a) dUMP and BW1843U89 and (b) dUMP and CB3717. Connolly surface represen-
tations for the active sites surrounding (c) BW1843U89 and (d) CB3717.
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Fig. 5. (a) Ligand-induced conformational changes between PcTS/BW1843U89 (green) and PcTS/CB3717 (blue). (b) Superposition of seven structures of
TS: TS from Escherichia coli bound to dUMP and either CB3717, BW1843U89 or ZD1694, PcTS bound to dUMP and either CB3717 or BW1843U89
and TS from Lactobacillus casei bound to A156 or MR29. Individual residues related by sequence alignment are shown in a single color and all resi-
dues of EcTS in the unbound, apo, form are shown in dark blue.
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repulsion between its atoms and the protein atoms. More
drastic enzyme rearrangement is needed in order to correct
the discrepancies of the cross-docked ligands (hence the
rigid receptor problem). Knegtel et al. [4] also observe
lower energy scores when a ligand is docked into its re-
spective site and higher energy scores when docked into
the same site with a new conformation. Yet we know from
solution experiments that both compounds are potent
PcTS inhibitors: CB3717 has an IC50 value of 90 nM
for PcTS [12] and BW1843U89 has a Ki value of 16 nM.
Therefore choosing one structure and applying the rigid
receptor assumption imposes a bias for the outcome of the
experiment and excludes potentially excellent inhibitors
from consideration.
A second computational experiment investigated how
many molecules from a database search would receive
good energy scores in both conformations of PcTS. A
subset of molecules (110 070 compounds) from the Avail-
able Chemicals Database (ACD) 97.0 was docked, main-
taining a rigid conformation, into the active sites of both
crystal structures and scored using the same force-¢eld
scoring algorithm. Only 42 compounds are common to
both lists of the top 500 compounds and furthermore
the ranking order of these 42 compounds is not preserved.
Again, employing only one of two enzyme conformations
as a receptor imparts a bias into the selection of low-en-
ergy scoring candidate compounds.
Another conclusion from the database docking experi-
ment is that BW1843U89, which has an energy score of
344.7, would not be selected in the list of 500 top-scoring
compounds if the PcTS/dUMP/CB3717 model were the
only one available, despite a 16 nM Ki value in solution.
Likewise, CB3717, with an energy score of 332.8, would
not be selected in the list of 500 top-scoring compounds if
the PcTS/dUMP/BW1843U89 model were the only one
available, despite its IC50 of 90 nM. Conversely,
BW1843U89 receives a better score than any other small
molecule in the database when docked into its own recep-
tor site and CB3717 receives a score within the top 40
ligands when docked into its own site.
A third experiment examined whether treating the li-
gands as £exible molecules but maintaining a rigid site
ameliorated the rigid receptor problem. The same swap-
ping experiment outlined above for the rigid ligands was
repeated with £exible ligands. In this experiment, torsion
angles of the ligand were allowed to vary (results tabulated
in Table 2). In this scenario the energy scores for the two
ligands are closer (351.7 for CB3717 docked into the
BW1843U89 model and 356.6 for BW1843U89 docked
into its own site) when the site is derived from the
BW1843U89 model, a tightly closed active site. However,
when the scores of the single £exible ligands are compared
to the scores from the subset of the ACD when docked
£exibly into the sites, it is evident that the score for
CB3717 falls at the bottom of the list of top 500 scoring
compounds and therefore would be unlikely to be selected
for further investigation. The energy scores for the two
ligands are still not comparable when the more open active
site from the CB3717 model is used (357.5 for CB3717
docked into its own site, 348.6 for BW1843U89 docked
into the site from the CB3717 model). The score for
BW1843U89 docked £exibly into the site from PcTS/
dUMP/CB3717 does not fall within the range of the top
500 scoring compounds and therefore BW1843U89 prob-
ably would not be selected for further investigation. In
addition, on closer examination of the docked conforma-
tion of the £exible ligands, the ¢nal conformation of the
ligand is not the crystallographically observed conforma-
tion (rmsd 3.18 Aî for BW1843U89 and rmsd 3.78 Aî for
CB3717). In conclusion, treating the ligand £exibly, either
with discrete torsion angles or as a fully £exible ligand,
may allow a conformation that will ¢t the altered active
site. That ligand conformation, however, may exhibit large
deviations from crystallographically-observed conforma-
tions.
2.4. Identi¢cation of ligand-induced conformational changes
using structure comparison
With the goal of developing a minimal manifold of
accessible conformations of an active site for more ac-
curate docking and scoring experiments, principal resi-
dues responsible for conformational changes were identi-
¢ed with a structure-based comparison. Conformational
Table 3
Derivation of an algorithm for prediction of £exible side chains in TS
Residues in active site forming
interactions with inhibitor
Hydrophobic residues
and loop residues
Hydrophobic residues with available
space in site and loop residues
Altered conformers revealed by
comparison of structures
F58 F58 F58 F58
E65
I86 I86 I86 I86
W87 W87
D202
L205 L205 L205
G206
F209 F209 F209 F209
M295 M295 M295
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changes are noticeable in a comparison of structures of
PcTS bound to either BW1843U89 or CB3717, an antifo-
late closely related to the cofactor. The two PcTS struc-
tures share the same crystal packing arrangement and
have an overall rms deviation of 0.66 Aî for all CK atoms.
A few key hydrophobic residues in PcTS undergo con-
formational changes in order to form ideal van der Waals
interactions with the isoindolinone moiety of BW1843U89
(see Fig. 5a). The benzoquinazoline moiety of BW1843U89
lies in the same space and orientation, immediately below
the pyrimidine and ribose rings of dUMP, as the quinazo-
line ring of CB3717. The benzoquinazoline moiety,
although larger than the quinazoline, or the pterin group
of the cofactor (see Fig. 2), does not induce any enzyme
accommodation since the third ring occupies the same
space as the propargyl group. The isoindolinone moiety
of BW1843U89, however, lies in a plane 90‡ from the
p-aminobenzoic acid moiety of CB3717. Importantly,
Phe 209 rotates 90‡ away, changing its rotamer, from its
conformation in the CB3717 structure to form a strong
stacking arrangement with the isoindolinone while Ile 86
translates 1.2 Aî toward the active site, continuing the
stacking arrangement. The two neighboring residues on
each side of Ile 86 also translate 0.8^1.3 Aî toward the
active site. The backbone of Phe 58, near the glutamate
tail, shifts 0.7 Aî away from the inhibitor in order to avoid
a steric con£ict. This shift removes the potential hydrogen
bond between the backbone of Phe 58 and the glutamate
tail that is formed in the PcTS/CB3717 complex. Finally,
residues 243^251 move 1.2^1.4 Aî toward the active site in
the BW1843U89 complex, completing the closure of the
hydrophobic pocket comprised of the isoindolinone, Phe
209, Leu 205 and Met 293.
PcTS and TS from Escherichia coli (EcTS) undergo sim-
ilar conformational changes on binding BW1843U89, em-
phasizing the importance of the increased hydrophobic
interactions of the enzyme with the inhibitor and espe-
cially with the isoindolinone moiety. Two structures of
EcTS were compared: EcTS/dUMP/CB3717 [24] and
EcTS/dUMP/BW1843U89 [20,21], both in the same space
group and with the same unit cell dimensions. Similar to
PcTS, Phe 176 from EcTS (PcTS:F209) rotates 90‡ to
stack against the isoindolinone of BW1843U89 and His
51 (PcTS:F58) shifts 1.1 Aî away from the active site to
remove steric con£icts with the glutamate tail. Preserving
the similarity in conformational change, Ile 79 (PcTS:I86)
stacks against the opposite face of the isoindolinone in
both structures.
Structures of TS bound in ternary complexes with vary-
ing ligands were compared (Fig. 5b) in order to determine
the relative active site plasticity over several species and
ligand combinations. The ligands involved include
CB3717, BW1843U89, ZD1694 (all antifolate derivatives)
as well as A156 and MR29, two phenolphthalein deriva-
tives with very di¡erent binding motifs. It is evident from
this comparison that Phe 209, Ile 86, and Asn 90 (Trp in
prokaryotic species) change conformation depending on
the species and ligand bound. Asn 90 (for which the pro-
karyotic substitution, Trp, undergoes conformational
change) changes its rotamer in the presence of inhibitors
that are unrelated to the antifolate sca¡old. The polar
residues Asn 210, Asp 202, and Tyr 242 remain relatively
¢xed, independent of the ligand bound or the species
studied. Phe 58 (PcTS) is a histidine in the prokaryotic
species and this side chain adopts a di¡erent conforma-
tion. His 245 adopts a di¡erent conformation in the struc-
ture of PcTS bound to dUMP and CB3717 but otherwise
remains ¢xed. The apo structure of EcTS is shown in Fig.
5b in dark blue and represents the conformational change
from the unbound form of the enzyme to the ternary
bound form, also revealing the £exibility of the hydropho-
bic residues. From this comparison it is evident that the
hydrophobic residues are subject to ligand-induced accom-
modation while the polar residues do not undergo confor-
mational changes in order to form hydrogen bonds.
In subsequent experiments (Fritz et al., in preparation)
we show, using entirely novel inhibitors of TS unrelated to
any of those mentioned above, that the same residues
provide £exibility and accommodate binding, independ-
ently suggesting that common elements of the protein tar-
get site do provide for plasticity in a general way.
2.5. Can we predict £exible residues within a single crystal
structure?
In order to predict £exible active site residues using a
single crystal structure, we derived a simple selection
scheme to identify the residues that are most crucial to
the conformational change. This scheme is based on a
structural evaluation of ligand-induced conformational
changes from several enzymes including thymidylate syn-
thase, glycogen phosphorylase, aldose reductase and hu-
man immunode¢ciency virus (HIV) reverse transcriptase.
The principles have been incorporated in an algorithm for
£exible side-chain selection, outlined in Table 3 and de-
scribed in detail below.
1. Include all residues in the active site capable of inter-
acting with the inhibitor.
2. Select hydrophobic residues and residues belonging to
loop regions from this list.
3. Retain loop residues and further select for hydrophobic
residues that allow room for conformational changes,
determined by assessing the steric hindrance of ro-
tamers of the side chain.
4. If two structures of the enzyme are available, compare
the two structures to validate the choice of residues
from steps one through three and add any additional
residues exhibiting a conformational change. In three
cases of our application, including TS, this latter razor
did not lead to new additions.
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After all residues in the active site have been tabulated
(step 1), a series of eliminations leaves a small number of
residues predicted to be capable of conformational change.
In the ¢rst step of elimination, step 2 of the algorithm,
hydrophobic residues and loop residues are maintained
from the initial list of active site residues.
Conformational changes of hydrophobic residues that
improve van der Waals interactions with inhibitor atoms
are emphasized in an analysis of enzymes that undergo the
largest ligand-induced changes. These include seven struc-
tures of TS, and therefore are included in an algorithm for
predicting £exible residues. In PcTS, Phe 209 rotates 90‡
to form a stacking interaction with the isoindolinone and
Ile 86 shifts 1.3 Aî to continue the stacking interaction on
the other side of the isoindolinone.
There are several additional examples that reveal an
emphasis on hydrophobic residues in ligand-induced con-
formational change. Bay W1807, a potent inhibitor for
glycogen phosphorylase, is almost completely buried with-
in the protein due to the rearrangement of several hydro-
phobic residues for improved interaction with the inhibitor
[25]. In further examples, hydrophobic residues in the ac-
tive site of aldose reductase undergo signi¢cant shifts in
response to the inhibitors zopolrestat [26] and tolrestat [27]
and HIV reverse transcriptase binds dissimilar ligands
through accommodation of hydrophobic residues [28]. Da-
vis and Teague [29] recently reviewed the important role of
hydrophobic interactions in ligand-induced conformation-
al changes.
Included in step 2, polar residues are removed from the
list since hydrogen bond formation does not appear to
drive conformational changes as much as hydrophobic
residues, as evidenced from the comparison of these TS
structures and from structures of many other enzymes
published in the literature [29]. There are three enzyme-
mediated hydrogen bonds from PcTS to BW1843U89. The
residues that form hydrogen bonds to the inhibitor do so
if the distance and geometry are correct but do not distort
the enzyme conformation if not. Also, it is evident that the
enzyme forms two more hydrogen bonds to CB3717 than
it does to BW1843U89 and yet BW1843U89 (Ki = 16 nM)
has a smaller inhibition constant for PcTS than CB3717
(Ki = 90 nM). Therefore, sacri¢cing two hydrogen bonds
while gaining hydrophobic interactions can result in a
smaller inhibition constant.
Hydrogen bond formation in the enzyme glycogen
phosphorylase also does not appear to determine either
the conformation of the enzyme or the e⁄cacy of its in-
hibitors. Glucose 6-phosphate, the natural substrate, has
two additional hydrogen bonds as compared to the potent
inhibitor, Bay W1807, yet Bay W1807 has optimized hy-
drophobic interactions with Phe 196 and Val 45P in order
to e¡ectively inhibit the enzyme [25]. Electrostatic interac-
tions and hydrogen bond formation play a very minor role
for inhibitors of aldose reductase [27] and HIV reverse
transcriptase [28].
Residues in loop regions that are capable of interacting
with the inhibitor are also retained as potential candidates
for plastic adaptation to a ligand since these residues are
less constrained than residues in the core of the enzyme.
For TS, hydrophobic residues Ile 86, Phe 209, Trp 87, Met
295, Leu 205, as well as Phe 58, a loop residue, are re-
tained at this step.
In step 3, a second series of elimination, loop residues
and hydrophobic residues with space for rotamer variation
are retained as potential candidates. For each hydrophobic
residue, each side-chain rotamer is tested and a bump
check is used to determine whether su⁄cient space exists
for that conformation. For this study, the rotamer library,
totaling 153 rotameric states for all residues, was deter-
mined from 240 high resolution (1.7 Aî or higher) protein
structures and was ¢ltered to remove mis¢t conformations
[30]. If no other rotamer position is valid for a particular
side chain, that residue is eliminated from the list of can-
didates. This elimination scheme disallows residue Trp 87
from TS, reducing the list of £exible candidates to Phe
209, Ile 86, Met 295 and Leu 205 as well as the loop
residue, Phe 58. Without multiple crystal structures, these
residues (present in column three of Table 3) would rep-
resent the list of potential £exible candidates.
In the fourth and ¢nal step, column four of Table 3, any
existing crystal structures of the receptor are compared.
This comparison can be viewed as an independent crite-
rion to validate the original choice of £exible residues, or
can add or eliminate residues from that list. For TS, hy-
drophobic residues Phe 209 and Ile 86 are retained as
potential £exible residues, as well as Phe 58, because of
drastic conformational changes that take place in the ex-
perimental structures at those sites. In the comparison of
structures of PcTS/dUMP/BW1843U89 or CB3717, there
are no major conformational changes near the benzoqui-
nazoline binding pocket and therefore, for the ensuing
comparison of docking BW1843U89 versus CB3717
only, Met 295 and Leu 205, two residues that interact
with the benzoquinazoline group, are not included as
£exible residues. When other ligands, including other
pterin or quinazoline-based inhibitors, are docked, the
contributions from Met 295 and Leu 205 should be con-
sidered.
This scheme for predicting £exible residues at the active
site was also validated when applied to other enzymes
known to exhibit ligand-induced accommodation. Apply-
ing this predictive scheme to aldose reductase yields hy-
drophobic residues Phe 122, Tyr 48, Trp 20, Leu 300, Trp
79 and Trp 111 after step 2 where all hydrophobic and
loop residues interacting with the inhibitor are retained as
potential candidates. Step 3 retains residues with space for
rotamer variation, eliminating all other residues and leav-
ing Phe 122 and Leu 300 as potential £exible residues.
These two remaining candidate £exible residues, Phe 122
and Leu 300, have been noted by the authors to undergo
major conformational changes in a comparison of struc-
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tures of the enzyme bound to either tolrestat or sorbinol
[27].
While these rules are more complex than simply using
the crystallographic temperature factors associated with
residues, they are also more complete. It should be noted
that crystallographic temperature factors do not necessa-
rily de¢ne all £exible regions in a protein. A surface loop
on a protein may have high temperature factors, depicting
a range of motion, but a buried residue undergoing a
rotamer shift may have low temperature factors in each
alternative position. In PcTS, Phe 209 has a low temper-
ature factor (average 12.8 for the residue, 22.2 for the
molecule) in rotamer one in the structure with dUMP
and CB3717 and also in rotamer two (average 24.9 for
the residue, 31.07 for the molecule) in the structure with
dUMP and BW1843U89. Therefore, residues with high
temperature factors do not indicate the entire set of £ex-
ible residues in a protein.
2.6. De¢ning a £exible receptor
For this enzyme, the discrepancy of rigid receptor dock-
ing scores was reduced by applying the rules of prediction
of conformational change to identify three £exible residues
in the active site of PcTS. Two strategies were compared:
1) switching the conformations of the three £exible resi-
dues in one site to those seen in the other site and docking
the inhibitors and, 2) varying the rotamers of the £exible
residues prior to docking the inhibitors. The second strat-
egy is preferred since it uses no prior knowledge of the
conformational change and can be employed without the
existence of multiple structures. Employing the ¢rst strat-
egy, switching the conformations of only three residues
from those in the PcTS/dUMP/CB3717 structure to those
seen in the PcTS/dUMP/BW1843U89 structure, was a
proof-of-concept test that shows that improved docking
scores could result from the modi¢cation of only a small
number of residues in the active site. With this switch in
the PcTS/dUMP/CB3717 structure, for example, the dock-
ing score for BW1843U89 improves to 355.1 (from 344.7
in the unaltered PcTS/dUMP/CB3717 structure).
The goal of this work, however, is to achieve an accu-
rate minimal manifold of active site conformations with-
out the prior knowledge of multiple structures and there-
fore this manifold was achieved with a rotamer library for
the identi¢ed side chains. Using both conformations of the
active site of PcTS, the rotamers of Phe 209, Ile 86 and
Phe 58 were varied according to the rotamer library com-
posed by Lovell et al. [30], which contains approximately
four rotamers per side chain only, and BW1843U89 and
CB3717 were docked into the resulting remodeled active
site. Rotamer variation was chosen as a method for gen-
erating new protein conformations since it has the poten-
tial to bring residues into position to interact with a ligand
or to remove a potential clash between a residue and li-
gand as well as representing a limited, low-energy subset
of new conformations. We also made the simplifying as-
sumption that all rotamers are iso-energetic. In this case,
the question we asked was whether any one of these ro-
tamer combinations would give an acceptably good score
for the known ligand. Therefore we chose rotamers that
were close to the conformation of the ‘opposite’ structure.
For example, in docking CB3717 into the BW1843U89
structure, we chose rotamers for Phe 209, Ile 86 and Phe
58 that best represented the conformations of those resi-
dues in the CB3717 structure, and vice versa for docking
BW1843U89 into the CB3717 structure. The structure of
the enzyme with docked inhibitor was minimized with a
simple conjugate gradient minimization [31].
In any genuine case, without the knowledge of the struc-
ture of a particular ligand/enzyme combination, it would
be necessary to compute the entire manifold of structures
based on di¡erent rotamers for each £exible residue and
dock the ligands against each structure. We used a ro-
tamer library with 153 total states for all residues. This
library was su⁄cient to predict a correct alternative
conformation for the identi¢ed three residues and the
manifold of possible structures with alternative conforma-
tions is represented by only 12 structures (4 rotamers per
3 residues). Docking a database of possible inhibitors
against the entire manifold is computationally manage-
able. In a case where ¢ner sampling of rotamers is desired,
a very comprehensive rotamer search using a large library
such as that described by De Maeyer et al. [32], including
859 rotamer states, could be explored, given the limited
number of residues for which alternative conformations
need to be predicted.
The energy score for BW1843U89 docked into the
newly remodeled PcTS receptor from the CB3717 struc-
ture, using rotamer variation, is 351.5 (Fig. 6a and Table
2), re£ecting a value much closer to that of CB3717
docked into its own active site (352.9). The energy score
for CB3717 docked into the remodeled receptor from the
BW1843U89 structure is 349.7 (Fig. 6b and Table 2). At
this step, minimization of the structure of the enzyme with
the docked inhibitor present is important for an accurate
determination of the energy score since before minimiza-
tion the scores for the BW1843U89 and CB3717 com-
pounds were 343.7 and 340.6, respectively. Both new
scores show a great reduction in the discrepancy of energy
scores for two potent inhibitors into the same site with
alternate conformations. The drastic improvement in en-
ergy scores for docking either BW1843U89 or CB3717
into the remodeled, minimized receptors represents a large
step toward the solution of the rigid receptor problem.
3. Signi¢cance
It is absolutely necessary to include receptor side-chain
£exibility during the search for novel inhibitors in docking
and scoring experiments in order to properly model ac-
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tive sites with conformational £exibility. Two known in-
hibitors, BW1843U89 and CB3717, of TS, an enzyme
that undergoes signi¢cant ligand-induced conformational
changes, receive poor scores when computationally docked
into the protein crystal structure from the complex with
the other ligand, revealing the breakdown of the rigid
receptor search model. With an emphasis on the role of
hydrophobic residues in conformational changes, a stan-
dard seen with TS and other enzymes, it is possible to
identify the principal side chains responsible for ligand-
induced structural accommodation using the predictive al-
gorithm SOFTSPOTS presented here. Varying the rotamer
positions of only the side chains (generated in PLASTIC)
allows the necessary active site plasticity that minimizes
the discrepancy of energy scores of potent inhibitors, as
compared with their ranking in experimental determina-
tions. This algorithm likewise makes the conformational
sampling tractable computationally. With the procedures
described here it is not necessary to have additional struc-
tural information beyond a single inhibitor bound enzyme
structure in order to identify £exible residues in an enzyme
active site, apply a rotamer database to create a minimal
manifold of new conformations, and dock against that
manifold to dramatically improve discovery and scoring
of new candidate inhibitors.
4. Materials and methods
4.1. Expression and assays
PcTS was expressed and puri¢ed as described previously [33].
Enzyme activity was assayed spectrophotometrically according to
the methods of Wahba and Friedkin [34]. Inhibition assays mea-
sured the initial velocities of reactions with 1.9 Wg enzyme, 80 WM
dUMP, 100 WM mTHF and varying concentrations of inhibitor.
Since the ratio of the total enzyme to Ki value was much greater
than 1000, the data were plotted as vo/vi vs. It/(13v1/vo). The
slope of this line yields the Ki value [35].
4.2. Crystallization
100 WM enzyme, 2 mM BW1843U89, 2.2 mM dUMP and 2.2
mM DTT were mixed and allowed to incubate for 1 h. Hanging
drop crystallizations used a well solution of 14.5% PEG 8000,
0.25 M (NH4)2SO4, 5 mM DTT, 100 mM Tris pH 7.4. Crystals
grew within 5 days. The crystals belong to the space group P21
and have unit cell dimensions: a = 55 Aî , b = 66 Aî , c = 184 Aî ,
L= 90.2.
4.3. Data collection
Data were collected at 100 K on a Mar image plate at Stanford
Synchrotron Radiation Laboratory, beamline 9-1. The data were
indexed, merged and scaled with the program DENZO [36] and
converted to structure factors with the program, Truncate, from
the CCP4 package [37].
4.4. Structure solution
The structure was solved using the AMoRe molecular replace-
ment method [38] with a model of PcTS [15] from which all
ligands were removed. Two molecules of the dimeric enzyme
were located in the asymmetric unit with a starting Rfactor of
36%. After setting aside 10% of the re£ections for a free R cal-
culation, the model was re¢ned with 50 cycles of conjugate gra-
dient re¢nement [31]. Two-fold non-crystallographic symmetry
constraints were applied to the two dimers but the monomers
within each dimer were structurally independent and remained
so during the entire course of the re¢nement. Electron density
for the ligands was clear from the initial maps and therefore
the ligands were placed in the active site [39] and included in
the re¢nement. The model was subjected to simulated annealing
re¢nement, manually rebuilt from simulated annealed omit maps
and re¢ned with conjugate gradient minimizations. Water mole-
cules with 3c di¡erence density (Fo3Fc) were included in the ¢nal
calculations. The ¢nal model with re¢ned values of position and
temperature factors converged with the residuals Rfree = 0.247 and
Rcryst = 0.216.
Fig. 6. Docked conformations of antifolates in the remodeled receptors. (a) CB3717 (red) docked into the altered PcTS/dUMP/BW1843U89 structure
with new rotamer conformations for the three identi¢ed £exible residues in the active site. (b) BW1843U89 (red) docked into the altered PcTS/dUMP/
CB3717 structure. dUMP is also depicted in red, all protein residues are shown in black.
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4.5. Docking and scoring
Computational chemistry experiments were carried out with
the program DOCK 4.0 [40] and its associated programs. The
active sites of the two structures of PcTS bound to dUMP and
either CB3717 or BW1843U89 formed the target receptors. All
water molecules and the inhibitor present in the ternary bound
structure were removed but the substrate, dUMP, was retained
since dUMP forms an essential binding surface for inhibitors.
Proton positions and charges were calculated for these coordi-
nates using SYBYL 6.5 (Tripos Associates, St. Louis, MO) and
an AMBER united atom representation [41]. Spheres ¢lling the
active site cavity were calculated with the program, SPHGEN.
The active sites were probed with 110 070 molecules from the
ACD 97.0 (MDL Inc., San Leandro, CA) representing those
with more ‘drug-like’ characteristics (no known toxicity, molec-
ular weight less than 600, no charges greater than 2 or less than
32). Four hundred orientations were sampled for each molecule
and those that passed a steric ¢lter, using a bump grid [23], were
scored using a combination of van der Waals and electrostatic
potentials as calculated by CHEMGRID [23,42].
Flexible docking experiments were carried out using the an-
chor-¢rst search algorithm described in Leach et al. [43]. This
algorithm divides each potential ligand at rotatable bonds and
initially docks and minimizes an anchor derived from one of these
segments. Remaining segments are re-attached to the anchor dur-
ing the conformational search.
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